Clinical Trial Update: Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating ABT-712 for moderate to severe chronic low back pain has completed. Results were posted on 2013-12-23.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Back Pain

Drugs mentioned

• ABT-712

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Chronic Low Back Pain | Phase 3 | Status: COMPLETED | Results posted: 2013-12-23